These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18321159)

  • 1. Single acute-dose and repeat-doses toxicity of anti-HIV-1 PNA TAR-penetratin conjugate after intraperitoneal administration to mice.
    Chaubey B; Tripathi S; Pandey VN
    Oligonucleotides; 2008; 18(1):9-20. PubMed ID: 18321159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.
    Upadhyay A; Ponzio NM; Pandey VN
    Oligonucleotides; 2008 Dec; 18(4):329-35. PubMed ID: 19006449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.
    Ganguly S; Chaubey B; Tripathi S; Upadhyay A; Neti PV; Howell RW; Pandey VN
    Oligonucleotides; 2008 Sep; 18(3):277-86. PubMed ID: 18729823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
    Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
    J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties.
    Chaubey B; Tripathi S; Ganguly S; Harris D; Casale RA; Pandey VN
    Virology; 2005 Jan; 331(2):418-28. PubMed ID: 15629784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
    Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
    Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
    Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
    Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
    Tan XX; Actor JK; Chen Y
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient biodelivery system for antisense polyamide nucleic acid (PNA).
    Mehiri M; Upert G; Tripathi S; Di Giorgio A; Condom R; Pandey VN; Patino N
    Oligonucleotides; 2008 Sep; 18(3):245-56. PubMed ID: 18707540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of RNA cleavage catalyzed by sequence specific polyamide nucleic acid-neamine conjugate.
    Chaubey B; Tripathi S; Désiré J; Baussanne I; Décout JL; Pandey VN
    Oligonucleotides; 2007; 17(3):302-13. PubMed ID: 17854270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR binding.
    Depecker G; Patino N; Di Giorgio C; Terreux R; Cabrol-Bass D; Bailly C; Aubertin AM; Condom R
    Org Biomol Chem; 2004 Jan; 2(1):74-9. PubMed ID: 14737662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
    Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
    Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.
    Mischiati C; Borgatti M; Feriotto G; Rutigliano C; Breda L; Bianchi N; Gambari R
    Int J Mol Med; 2002 Jun; 9(6):633-9. PubMed ID: 12011981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
    Jia F; Balaji BS; Gallazzi F; Lewis MR
    Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain.
    Fraternale A; Paoletti MF; Casabianca A; Orlandi C; Millo E; Balestra E; Damonte G; Perno CF; Magnani M
    J Drug Target; 2009 May; 17(4):278-85. PubMed ID: 19255894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid.
    Albertshofer K; Siwkowski AM; Wancewicz EV; Esau CC; Watanabe T; Nishihara KC; Kinberger GA; Malik L; Eldrup AB; Manoharan M; Geary RS; Monia BP; Swayze EE; Griffey RH; Bennett CF; Maier MA
    J Med Chem; 2005 Oct; 48(21):6741-9. PubMed ID: 16220989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.